Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2016 FY- Text added to 2017 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
adult, aforementioned, alpha, ASX, auditor, Australian, back, barred, Bulletin, chose, Concurrently, correspondingly, daratumumab, deletion, error, erythropoietin, escrow, exact, exceeding, expedite, facilitate, fast, faster, fedratinib, FibroGen, flat, GAAP, Genmab, heavily, heightened, HMA, hydroxylase, interrupt, JSC, justification, led, loosen, membership, Narrative, Notwithstanding, occupy, officially, offshore, opted, passed, PCAOB, pretreatment, prolyl, Promedior, Promega, qui, readily, reconsider, remeasured, remeasurement, renegotiated, renegotiation, repatriated, resource, retinoic, rolling, roxadustat, scrutiny, SDX, sEPO, serum, Sienna, Supplementary, talacotuzumab, taxation, TI, ticker, top, track, urge, voluntarily, wrongdoing
Removed:
accommodate, advancing, advice, allegedly, complaint, complication, consultation, county, died, discount, dissemination, encode, esophageal, Gilead, halted, inAssociation, inInternal, inMayo, inventor, issuing, larger, leased, Mateo, misleading, momelotinib, motion, paclitaxel, persistent, PositionJohn, precluded, prosecuted, purporting, removed, reversal, reversibility, signal, toxicity, underwriting, underwritten, unspecified, utilizing, week, weekly
Valuein 2016 FY filing- Value in 2017 FY filing
Original filings
Filing view